Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.

Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.

<h4>Background</h4>There is an unmet need for disease-modifying therapies to improve ambulatory function in disabled subjects with multiple sclerosis.<h4>Objectives</h4>Assess the effects of natalizumab on ambulatory function in disabled subjects with relapsing-remitting mult...

Full description

Saved in:
Bibliographic Details
Main Authors: Diego Cadavid, Stephanie Jurgensen, Sophia Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0053297&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items